Anatomy of a monograph inside front cover |
|
Contributors and consultants |
|
v | |
How to use Nursing 2024 Drug Handbook® |
|
vi | |
Quick guide to special symbols, logos, and highlighted terms |
|
ix | |
Guide to abbreviations |
|
x | |
|
|
|
1 Drug actions, interactions, and reactions |
|
|
1 | (5) |
|
2 Drug therapy across the lifespan |
|
|
6 | (7) |
|
3 Safe drug administration |
|
|
13 | (10) |
|
4 Selected therapeutic drug classifications |
|
|
23 | (40) |
|
Alphabetical listing of drugs by generic name |
|
|
63 | |
|
|
1582 | (27) |
|
|
1609 | (182) |
|
1 Nursing process: Patient safety during drug therapy |
|
|
1609 | (1) |
|
2 Decision tree: Deciding about medication administration |
|
|
1610 | (1) |
|
3 Avoiding common drug errors: Best practices and prevention |
|
|
1611 | (3) |
|
4 Abbreviations to avoid (The Joint Commission) |
|
|
1614 | (1) |
|
5 Do not use: Dangerous abbreviations, symbols, and dose designations (ISMP Canada) |
|
|
1615 | (1) |
|
6 Therapeutic drug monitoring guidelines |
|
|
1616 | (8) |
|
7 Pregnancy risk categories: The FDA's Final Rule |
|
|
1624 | (1) |
|
8 Controlled substance schedules |
|
|
1624 | (1) |
|
9 Canadian National Drug Schedules |
|
|
1625 | (1) |
|
10 Safe disposal of unused drugs: What patients need to know |
|
|
1626 | (2) |
|
11 Prescription drug abuse: Identifying and treating toxicity |
|
|
1628 | (3) |
|
12 Serotonin syndrome: What you should know to protect your patient |
|
|
1631 | (1) |
|
13 Tumor lysis syndrome: A life-threatening emergency |
|
|
1632 | (1) |
|
14 Severe cutaneous adverse reactions |
|
|
1633 | (2) |
|
|
1635 | (1) |
|
16 Understanding biosimilar drugs |
|
|
1636 | (2) |
|
17 Antacids: Indications and dosages |
|
|
1638 | (1) |
|
18 Antidiarrheals: Indications and dosages |
|
|
1639 | (2) |
|
19 Laxatives: Indications and dosages |
|
|
1641 | (4) |
|
20 Vitamins and minerals: Indications and dosages |
|
|
1645 | (7) |
|
21 Additional OTC drugs: Indications and dosages |
|
|
1652 | (5) |
|
22 Common combination drugs: Indications and dosages |
|
|
1657 | (15) |
|
23 Antidotes: Indications and dosages |
|
|
1672 | (7) |
|
24 Selected ophthalmic drugs: Indications and dosages |
|
|
1679 | (8) |
|
25 Selected biologicals and blood derivatives: Indications and dosages |
|
|
1687 | (6) |
|
26 Vaccines and toxoids: Indications and dosages |
|
|
1693 | (8) |
|
27 Less commonly used drugs: Indications and dosages |
|
|
1701 | (90) |
Index |
|
1791 | |